Back to top

Image: Bigstock

Aptiv's (APTV) Q1 Earnings and Revenues Beat Estimates

Read MoreHide Full Article

Aptiv PLC (APTV - Free Report) reported first-quarter 2020 (ended Mar 31, 2020) earnings per share of 68 cents (on an adjusted basis), lower than the Zacks Consensus Estimate of 23 cents. Earnings decreased 37 cents year over year.

How Was the Estimate Revision Trend?

Investors should note that the earnings estimate revisions for Aptiv depicted a pessimistic picture prior to the earnings release. The stock had seen the Zacks Consensus Estimate for first-quarter 2020 earnings move down 48.4% over the last 30 days.

However, the company has an impressive earnings history having outperformed the Zacks Consensus Estimate in three of the last four quarters with an average beat of 8.9%.

Revenues Better Than Expected

Aptiv recorded total revenues of $3.23 billion which surpassed the Zacks Consensus Estimate of $2.89 billion. However, revenues compared unfavorably with the year-ago figure of $3.58 billion.

Aptiv PLC Price

Key Stats to Note: Adjusted operating income of $231 million fell 33% year over year. Adjusted operating income margin declined to 7.2% from 9.7% in the prior-year quarter.

Zacks Rank: Currently, Aptiv has a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.  

Check back later for our full write up on this Aptiv earnings report later!

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Aptiv PLC (APTV) - free report >>